488 related articles for article (PubMed ID: 16570766)
21. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic prevention or delay of type 2 diabetes mellitus.
Anderson DC
Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
[TBL] [Abstract][Full Text] [Related]
23. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
Liebl A
Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
[TBL] [Abstract][Full Text] [Related]
24. Prevention of type 2 diabetes: are we ready?
Bouche C; Goldfine AB
Minerva Med; 2003 Feb; 94(1):9-18. PubMed ID: 12719698
[TBL] [Abstract][Full Text] [Related]
25. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
[TBL] [Abstract][Full Text] [Related]
26. Lifestyle advice in preventing and treating type 2 diabetes.
Hunking P
J Fam Health Care; 2006; 16(4):109-12. PubMed ID: 17002268
[TBL] [Abstract][Full Text] [Related]
27. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
28. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
[No Abstract] [Full Text] [Related]
29. Diabetes prevention programs.
Ramachandran A; Snehalatha C
Med Clin North Am; 2011 Mar; 95(2):353-72, viii. PubMed ID: 21281838
[TBL] [Abstract][Full Text] [Related]
30. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
Fonseca VA
Clin Cornerstone; 2007; 8(2):10-8; discussion 19-20. PubMed ID: 18357952
[TBL] [Abstract][Full Text] [Related]
31. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients.
Hwang YC; Lee EY; Lee WJ; Cha BS; Yoon KH; Park KS; Lee MK
Metabolism; 2008 Apr; 57(4):479-87. PubMed ID: 18328348
[TBL] [Abstract][Full Text] [Related]
32. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
Guerrero-Romero F; Rodríguez-Morán M
Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
[TBL] [Abstract][Full Text] [Related]
33. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
[TBL] [Abstract][Full Text] [Related]
34. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
35. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
[TBL] [Abstract][Full Text] [Related]
36. [Thus to avoid complications of diabetes. To combine early].
MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
[No Abstract] [Full Text] [Related]
37. The prevention of type 2 diabetes: what is the evidence?
Chiasson JL; Brindisi MC; Rabasa-Lhoret R
Minerva Endocrinol; 2005 Sep; 30(3):179-91. PubMed ID: 16208307
[TBL] [Abstract][Full Text] [Related]
38. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
39. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiology of prediabetes.
Bhansali A; Dutta P
J Indian Med Assoc; 2005 Nov; 103(11):594-5, 599. PubMed ID: 16570762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]